Financial Statements

Bio-Rad Laboratories, Inc. (BIO)


-2.93 (-0.83%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 13,5079,2685,4713,722-
Net Income -3,6284,2463,8061,759361
Stock Dividends 68,20235,275-93,8213,361
Dividend Paid -68,184-35,282--3,831-
Retained Earnings 9,89813,5079,2685,4713,722

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 696694701509-
Annual Depreciation 9812391291639
Capital Expenditure -114-121-99-99-130
Net PPE 680696694701509

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -220264292347
New Purchases -371-451-345-1,305-2,060
Intangible and Goodwill 220264292347406

Bio-Rad Laboratories, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Bio-Rad Laboratories, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.